ERBB2 and non-small cell lung carcinoma: (Table 1) This patient had metastatic NSCLC which was HER2(−) by pathologic criteria (based on a pericardial effusion sample: HER2 2+, FISH 1.2); however, focal uptake in a right lung lesion was apparent, best visualized at the 72h time point with a positive T:B value of 6.7, remaining >1.5 across all timepoints.